Is your child currently experiencing inflammatory bowel disease (IBD) flare-ups?

A local clinical trial in the Moscow AR area is testing a potential new medication to see if it may reduce associated with IBD, Crohn’s disease (CD), or ulcerative colitis (UC).

If you’re concerned about how IBD affects your child’s life, find out more about the GI clinical research studies.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child is eligible.

Is your child currently experiencing inflammatory bowel disease (IBD) flare-ups?

A local clinical trial in the Montrose AR area is testing a potential new medication to see if it may reduce associated with IBD, Crohn’s disease (CD), or ulcerative colitis (UC).

If you’re concerned about how IBD affects your child’s life, find out more about the GI clinical research studies.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child is eligible.

Is your child currently experiencing inflammatory bowel disease (IBD) flare-ups?

A local clinical trial in the Monticello AR area is testing a potential new medication to see if it may reduce associated with IBD, Crohn’s disease (CD), or ulcerative colitis (UC).

If you’re concerned about how IBD affects your child’s life, find out more about the GI clinical research studies.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child is eligible.

Is your child currently experiencing inflammatory bowel disease (IBD) flare-ups?

A local clinical trial in the Mc Gehee AR area is testing a potential new medication to see if it may reduce associated with IBD, Crohn’s disease (CD), or ulcerative colitis (UC).

If you’re concerned about how IBD affects your child’s life, find out more about the GI clinical research studies.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child is eligible.

Is your child currently experiencing inflammatory bowel disease (IBD) flare-ups?

A local clinical trial in the Lake Village AR area is testing a potential new medication to see if it may reduce associated with IBD, Crohn’s disease (CD), or ulcerative colitis (UC).

If you’re concerned about how IBD affects your child’s life, find out more about the GI clinical research studies.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child is eligible.

Is your child currently experiencing inflammatory bowel disease (IBD) flare-ups?

A local clinical trial in the Kingsland AR area is testing a potential new medication to see if it may reduce associated with IBD, Crohn’s disease (CD), or ulcerative colitis (UC).

If you’re concerned about how IBD affects your child’s life, find out more about the GI clinical research studies.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child is eligible.

Is your child currently experiencing inflammatory bowel disease (IBD) flare-ups?

A local clinical trial in the Jersey AR area is testing a potential new medication to see if it may reduce associated with IBD, Crohn’s disease (CD), or ulcerative colitis (UC).

If you’re concerned about how IBD affects your child’s life, find out more about the GI clinical research studies.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child is eligible.

Is your child currently experiencing inflammatory bowel disease (IBD) flare-ups?

A local clinical trial in the Hermitage AR area is testing a potential new medication to see if it may reduce associated with IBD, Crohn’s disease (CD), or ulcerative colitis (UC).

If you’re concerned about how IBD affects your child’s life, find out more about the GI clinical research studies.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child is eligible.

Is your child currently experiencing inflammatory bowel disease (IBD) flare-ups?

A local clinical trial in the Hamburg AR area is testing a potential new medication to see if it may reduce associated with IBD, Crohn’s disease (CD), or ulcerative colitis (UC).

If you’re concerned about how IBD affects your child’s life, find out more about the GI clinical research studies.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child is eligible.

Is your child currently experiencing inflammatory bowel disease (IBD) flare-ups?

A local clinical trial in the Grady AR area is testing a potential new medication to see if it may reduce associated with IBD, Crohn’s disease (CD), or ulcerative colitis (UC).

If you’re concerned about how IBD affects your child’s life, find out more about the GI clinical research studies.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child is eligible.